SciBase Launches Nevisense Pilot at Leading University in Southeast Florida
WEST PALM BEACH, Fla., July 9, 2025 – SciBase AB, a pioneering company in dermatological diagnostics, announced today the commencement of a pilot program for its innovative Nevisense device at a leading university in Southeast Florida. This collaboration marks a significant step in advancing the accessibility and accuracy of skin cancer detection in the region.
The Nevisense system, a non-invasive diagnostic tool, utilizes electrical impedance spectroscopy (EIS) to analyze skin lesions. This advanced technology offers healthcare professionals a more comprehensive understanding of the cellular structure of a skin lesion, aiding in the early and accurate identification of potential skin cancers. The pilot program will involve the integration of Nevisense into the clinical workflow of the university’s dermatology department, allowing patients in Southeast Florida to benefit from this cutting-edge diagnostic solution.
“We are thrilled to partner with a prestigious institution like this leading university in Southeast Florida,” stated a SciBase spokesperson. “This pilot program is a testament to our commitment to making advanced dermatological diagnostics more widely available. We believe Nevisense will be a valuable asset to their clinicians, enhancing their ability to diagnose and manage skin conditions effectively, ultimately leading to better patient outcomes.”
Southeast Florida, with its high prevalence of skin cancer due to significant sun exposure, presents a critical need for improved diagnostic tools. The Nevisense system’s ability to provide objective, quantifiable data complements traditional visual assessment, offering a more precise method for evaluating suspicious moles and lesions. This can help reduce unnecessary biopsies and ensure that potentially malignant lesions are identified and treated promptly.
The pilot program is expected to gather valuable data on the real-world performance and clinical utility of Nevisense within a busy academic dermatology setting. This information will be crucial for further validating the system’s benefits and informing SciBase’s ongoing development and market strategies.
SciBase AB is dedicated to improving the lives of patients through innovative dermatological solutions. The launch of this pilot program in Southeast Florida underscores the company’s mission to bring advanced technology to the forefront of skin health management.
SciBase Launches Nevisense Pilot at Leading University in Southeast Florida
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Healthring published ‘SciBase Launches Nevisense Pilot at Leading University in Southeast Florida’ at 2025-07-09 06:07. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.